ICLR Stock Analysis: Buy, Sell, or Hold?
ICLR - Icon Plc
$116.38
-0.71 (-0.61%)
▼
5d:
-6.51%
30d:
+0.69%
90d:
+25.14%
HOLD
LOW Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 20, 2026
1d
Smart Money Accumulation
ICLR is down 6.5% this week, but smart money is accumulating calls. Top strike: $95 2026-07-17 with 324 OI. Call ratio: 92% View Scanner →
Strength: 7.5/10
Get Alerted When ICLR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ICLR shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: ICLR shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$104.13
Based on -3.1% avg growth
INTRINSIC VALUE TODAY
$64.66
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 10.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ICLR is currently trading at $116.38, which is considered fair relative to its 30-day fair value range of $108.20 to $121.18. The stock's valuation (Forward PE: 10.2) is in line with its historical norms (10.7). Remarkably, the market is currently pricing in an annual earnings decline of 1.7% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, ICLR is in a strong downtrend. Immediate support is located at $108.80, while resistance sits at $129.73.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $137.21 (+17.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ICLR is in a strong downtrend. Immediate support is located at $108.80, while resistance sits at $129.73.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $137.21 (+17.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$108.20 -
$121.18
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
75.8%
Protect Your Profits
Holding ICLR? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($137.21)
- CAUTION: Recommendation downgraded due to -6.5% 5-day decline
Trading Range Analysis
30-Day Trading Range
$108.20 -
$121.18
Current vs Trading Range
FAIR
Expected Move (7 Days)
±$10.33
(8.9%)
Support & Resistance Levels
Support Level
$108.80
Resistance Level
$129.73
Current Trend
Strong Downtrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
10.15
Wall Street Target
$137.21
(+17.9%)
Revenue Growth (YoY)
0.6%
Earnings Growth (YoY)
-98.7%
Profit Margin
7.4%
Valuation Discount vs History
-1.7% cheaper
PE vs Historical
10.2 vs 10.7
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.7%
(market-implied from PE analysis)
1-Year Target
$114.40
(-2%)
2-Year Target
$112.46
(-3%)
3-Year Target
$110.54
(-5%)
3-Yr Target (if PE normalizes)
(PE: 10→11)
$116.56
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.1, Growth: -10.2%)
$184.51
(+59%)
Base:
(SPY PE: 10.1, Growth: -10.2%)
$84.84
(-27%)
Bear:
(PE: 8.6, Growth: -10.2%)
$72.11
(-38%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (16x PE), but valuation improves significantly next year (10x PE) as earnings recover.
Trailing PE: 15.78 | Current EPS (TTM): $7.42
Bull Case
$199.07
(+71%)
Analyst growth 54.6%, PE expands to 17.4
Base Case
$180.97
(+56%)
Market implied 54.6%, PE stable at 15.8
Bear Case
$79.62
(-32%)
Severe decline -20.0%, PE contracts to 13.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 10.1 to 10.7
Stabilization Target:
$122.71
(+5.4%)
PE Expansion Potential:
+5.4%
Share & Embed Analysis
Last updated: May 18, 2026 8:19 AM ET
Data refreshes hourly during market hours. Next update: 9:19 AM
Data refreshes hourly during market hours. Next update: 9:19 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ICLR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$613 | 54 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$248 | 53 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$131 | 60 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$261 | 49 HOLD |
Advanced ICLR Option Strategies
Professional options setups generated by AI based on today's ICLR price and gamma walls.
